U.S. markets close in 2 hours 56 minutes
  • S&P 500

    4,325.09
    +5.03 (+0.12%)
     
  • Dow 30

    33,924.25
    -39.59 (-0.12%)
     
  • Nasdaq

    13,232.94
    +21.14 (+0.16%)
     
  • Russell 2000

    1,787.51
    +11.01 (+0.62%)
     
  • Crude Oil

    89.85
    -0.18 (-0.20%)
     
  • Gold

    1,935.70
    -9.90 (-0.51%)
     
  • Silver

    23.38
    -0.47 (-1.97%)
     
  • EUR/USD

    1.0593
    -0.0054 (-0.51%)
     
  • 10-Yr Bond

    4.5250
    +0.0870 (+1.96%)
     
  • GBP/USD

    1.2213
    -0.0028 (-0.23%)
     
  • USD/JPY

    148.8200
    +0.4600 (+0.31%)
     
  • Bitcoin USD

    26,322.07
    -252.37 (-0.95%)
     
  • CMC Crypto 200

    562.99
    +3.48 (+0.62%)
     
  • FTSE 100

    7,623.99
    -59.92 (-0.78%)
     
  • Nikkei 225

    32,678.62
    +276.21 (+0.85%)
     

AzurRx BioPharma To Acquire First Wave Bio For $229M

  • AzurRx BioPharma Inc (NASDAQ: AZRX) has agreed to acquire First Wave Bio Inc in a stock and cash transaction valued at $229 million, including milestone payments.

  • First Wave Bio is a clinical-stage biotechnology company specializing in developing gut-targeted, small molecule therapies for autoimmune inflammatory bowel diseases (IBD).

  • In conjunction with the acquisition, AzurRx will change its name to First Wave BioPharma and trade on NASDAQ under the new ticker symbol, FWBI, effective by September 23.

  • In January, AzurRx in-licensed from First Wave Bio the exclusive global rights to develop two niclosamide therapeutic indications for COVID-19-related GI infections and immune checkpoint inhibitor-associated colitis and diarrhea (ICI-AC) in advanced-stage cancer patients.

  • Following the acquisition of First Wave Bio, AzurRx's internal development pipeline will include three new clinical IBD indications.

  • Last week, AzurRx BioPharma announced a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares.

  • Also Read: Why AzurRx Stock Is Trading Higher After MS1819 Combo Therapy Data?

  • Price Action: AZRX shares are trading at $5.16 during the premarket session on the last check Monday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.